ARTICLE SUMMARY:
Recent high-profile senior leadership departures amid other tailwinds could derail NuVasive’s impressive trajectory, but newly named EVP innovation and strategy, Matt Link, formerly president for the US commercial division, discusses how the company’s innovation strategy is addressing the challenges of unmet clinical needs and helping it diversify beyond its core business in degenerative spine disease.
For many years NuVasive Inc. has been an outperformer in spine and one of a few pureplay, mid-sized entrants into the field that has successfully grabbed market share from industry leaders as they stumbled.
